Design of Two New Sulfur Derivatives of Perezone: In Silico Study Simulation Targeting PARP-1 and In Vitro Study Validation Using Cancer Cell Lines

Poly-ADP-Ribose Polymerase (PARP-1) is an overexpressed enzyme in several carcinomas; consequently, the design of PARP-1 inhibitors has acquired special attention. Hence, in the present study, three compounds ( - ) were produced through a Michael addition protocol, using phenylmethanethiol, 5-fluoro...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of molecular sciences 2024-01, Vol.25 (2), p.868
Hauptverfasser: Rubiales-Martínez, Alejandro, Martínez, Joel, Mera-Jiménez, Elvia, Pérez-Flores, Javier, Téllez-Isaías, Guillermo, Miranda Ruvalcaba, René, Hernández-Rodríguez, Maricarmen, Mancilla Percino, Teresa, Macías Pérez, Martha Edith, Nicolás-Vázquez, María Inés
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 2
container_start_page 868
container_title International journal of molecular sciences
container_volume 25
creator Rubiales-Martínez, Alejandro
Martínez, Joel
Mera-Jiménez, Elvia
Pérez-Flores, Javier
Téllez-Isaías, Guillermo
Miranda Ruvalcaba, René
Hernández-Rodríguez, Maricarmen
Mancilla Percino, Teresa
Macías Pérez, Martha Edith
Nicolás-Vázquez, María Inés
description Poly-ADP-Ribose Polymerase (PARP-1) is an overexpressed enzyme in several carcinomas; consequently, the design of PARP-1 inhibitors has acquired special attention. Hence, in the present study, three compounds ( - ) were produced through a Michael addition protocol, using phenylmethanethiol, 5-fluoro-2-mercaptobenzyl alcohol, and 4-mercaptophenylacetic acid, respectively, as nucleophiles and perezone as the substrate, expecting them to be convenient candidates that inhibit PARP-1. It is convenient to note that in the first stage of the whole study, the molecular dynamics (MD) simulations and the quantum chemistry studies of four secondary metabolites, i.e., perezone ( ), perezone angelate ( ), hydroxyperezone ( ), and hydroxyperezone monoangelate ( ), were performed, to investigate their interactions in the active site of PARP-1. Complementarily, a docking study of a set of eleven sulfur derivatives of perezone ( - ) was projected to explore novel compounds, with remarkable affinity to PARP-1. The molecules - provided the most adequate results; therefore, they were evaluated in vitro to determine their activity towards PARP-1, with having the best IC (0.317 µM) value. Additionally, theoretical calculations were carried out using the density functional theory (DFT) with the hybrid method B3LYP with a set of base functions 6-311++G(d,p), and the reactivity properties were compared between the natural derivatives of perezone and the three synthesized compounds, and the obtained results exhibited that has the best properties to bind with PARP-1. Finally, it is important to mention that displays significant inhibitory activity against MDA-MB-231 and MCF-7 cells, i.e., 145.01 and 83.17 µM, respectively.
doi_str_mv 10.3390/ijms25020868
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_2917867863</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A780876547</galeid><sourcerecordid>A780876547</sourcerecordid><originalsourceid>FETCH-LOGICAL-c424t-9d436fc44e0f512e2ba97b9db056d142138e91ab7eb76d40e9d22ce5e375d7a03</originalsourceid><addsrcrecordid>eNpt0stO3DAUAFALgQql3bGuLLHpoqGOH3Hc3WhoC9KIjjoD28iJb0YeJTa1ExD9jf5wHQ0UWlW25Ne51vUDoZOcnDGmyEe77SMVhJKyKPfQUc4pzQgp5P6L_iF6HeOWEMqoUK_QISupEIqzI_TrHKLdOOxbvL73-Aru8Wrs2jHgcwj2Tg_2DuK0uoQAP72DT_jS4ZXtbOPxahjNQxr0Y5egd3itwwYG6zZ4Ofu-zHKsnZn8jR3CE7_RnTU7fh0nOteugYDn0HV4YR3EN-ig1V2Et4_tMbr-8nk9v8gW375ezmeLrOGUD5kynBVtwzmQVuQUaK2VrJWpiShMOnrOSlC5riXUsjCcgDKUNiCASWGkJuwYvd_texv8jxHiUPU2NikN7cCPsaIql2WRKkv09B-69WNwKbtJlbKY0LPa6A4q61o_BN1Mm1YzWZLEBJdJnf1HpWKgT7fqoLVp_q-AD7uAJvgYA7TVbbC9Dg9VTqrpD1Qv_0Di7x5zHesezB_89OjsN_xNqtM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2918768633</pqid></control><display><type>article</type><title>Design of Two New Sulfur Derivatives of Perezone: In Silico Study Simulation Targeting PARP-1 and In Vitro Study Validation Using Cancer Cell Lines</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>PubMed Central</source><creator>Rubiales-Martínez, Alejandro ; Martínez, Joel ; Mera-Jiménez, Elvia ; Pérez-Flores, Javier ; Téllez-Isaías, Guillermo ; Miranda Ruvalcaba, René ; Hernández-Rodríguez, Maricarmen ; Mancilla Percino, Teresa ; Macías Pérez, Martha Edith ; Nicolás-Vázquez, María Inés</creator><creatorcontrib>Rubiales-Martínez, Alejandro ; Martínez, Joel ; Mera-Jiménez, Elvia ; Pérez-Flores, Javier ; Téllez-Isaías, Guillermo ; Miranda Ruvalcaba, René ; Hernández-Rodríguez, Maricarmen ; Mancilla Percino, Teresa ; Macías Pérez, Martha Edith ; Nicolás-Vázquez, María Inés</creatorcontrib><description>Poly-ADP-Ribose Polymerase (PARP-1) is an overexpressed enzyme in several carcinomas; consequently, the design of PARP-1 inhibitors has acquired special attention. Hence, in the present study, three compounds ( - ) were produced through a Michael addition protocol, using phenylmethanethiol, 5-fluoro-2-mercaptobenzyl alcohol, and 4-mercaptophenylacetic acid, respectively, as nucleophiles and perezone as the substrate, expecting them to be convenient candidates that inhibit PARP-1. It is convenient to note that in the first stage of the whole study, the molecular dynamics (MD) simulations and the quantum chemistry studies of four secondary metabolites, i.e., perezone ( ), perezone angelate ( ), hydroxyperezone ( ), and hydroxyperezone monoangelate ( ), were performed, to investigate their interactions in the active site of PARP-1. Complementarily, a docking study of a set of eleven sulfur derivatives of perezone ( - ) was projected to explore novel compounds, with remarkable affinity to PARP-1. The molecules - provided the most adequate results; therefore, they were evaluated in vitro to determine their activity towards PARP-1, with having the best IC (0.317 µM) value. Additionally, theoretical calculations were carried out using the density functional theory (DFT) with the hybrid method B3LYP with a set of base functions 6-311++G(d,p), and the reactivity properties were compared between the natural derivatives of perezone and the three synthesized compounds, and the obtained results exhibited that has the best properties to bind with PARP-1. Finally, it is important to mention that displays significant inhibitory activity against MDA-MB-231 and MCF-7 cells, i.e., 145.01 and 83.17 µM, respectively.</description><identifier>ISSN: 1422-0067</identifier><identifier>ISSN: 1661-6596</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms25020868</identifier><identifier>PMID: 38255943</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Amino acids ; Cancer ; Cell division ; Computer software industry ; Cyclohexenes ; Density functionals ; Design ; Development and progression ; Electrons ; Enzymes ; Equilibrium ; Genetic aspects ; Humans ; Hydrogen bonds ; Ligands ; MCF-7 Cells ; Molecular Dynamics Simulation ; Monosaccharides ; Neoplasms - drug therapy ; Oncology, Experimental ; Poly(ADP-ribose) Polymerase Inhibitors - pharmacology ; Proteins ; Sesquiterpenes ; Simulation ; Sugars ; Sulfur ; Sulfur compounds</subject><ispartof>International journal of molecular sciences, 2024-01, Vol.25 (2), p.868</ispartof><rights>COPYRIGHT 2024 MDPI AG</rights><rights>2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c424t-9d436fc44e0f512e2ba97b9db056d142138e91ab7eb76d40e9d22ce5e375d7a03</citedby><cites>FETCH-LOGICAL-c424t-9d436fc44e0f512e2ba97b9db056d142138e91ab7eb76d40e9d22ce5e375d7a03</cites><orcidid>0000-0002-2416-2747 ; 0000-0002-1979-5590 ; 0000-0002-6683-6738 ; 0000-0003-0722-5045 ; 0000-0001-9371-1095</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38255943$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rubiales-Martínez, Alejandro</creatorcontrib><creatorcontrib>Martínez, Joel</creatorcontrib><creatorcontrib>Mera-Jiménez, Elvia</creatorcontrib><creatorcontrib>Pérez-Flores, Javier</creatorcontrib><creatorcontrib>Téllez-Isaías, Guillermo</creatorcontrib><creatorcontrib>Miranda Ruvalcaba, René</creatorcontrib><creatorcontrib>Hernández-Rodríguez, Maricarmen</creatorcontrib><creatorcontrib>Mancilla Percino, Teresa</creatorcontrib><creatorcontrib>Macías Pérez, Martha Edith</creatorcontrib><creatorcontrib>Nicolás-Vázquez, María Inés</creatorcontrib><title>Design of Two New Sulfur Derivatives of Perezone: In Silico Study Simulation Targeting PARP-1 and In Vitro Study Validation Using Cancer Cell Lines</title><title>International journal of molecular sciences</title><addtitle>Int J Mol Sci</addtitle><description>Poly-ADP-Ribose Polymerase (PARP-1) is an overexpressed enzyme in several carcinomas; consequently, the design of PARP-1 inhibitors has acquired special attention. Hence, in the present study, three compounds ( - ) were produced through a Michael addition protocol, using phenylmethanethiol, 5-fluoro-2-mercaptobenzyl alcohol, and 4-mercaptophenylacetic acid, respectively, as nucleophiles and perezone as the substrate, expecting them to be convenient candidates that inhibit PARP-1. It is convenient to note that in the first stage of the whole study, the molecular dynamics (MD) simulations and the quantum chemistry studies of four secondary metabolites, i.e., perezone ( ), perezone angelate ( ), hydroxyperezone ( ), and hydroxyperezone monoangelate ( ), were performed, to investigate their interactions in the active site of PARP-1. Complementarily, a docking study of a set of eleven sulfur derivatives of perezone ( - ) was projected to explore novel compounds, with remarkable affinity to PARP-1. The molecules - provided the most adequate results; therefore, they were evaluated in vitro to determine their activity towards PARP-1, with having the best IC (0.317 µM) value. Additionally, theoretical calculations were carried out using the density functional theory (DFT) with the hybrid method B3LYP with a set of base functions 6-311++G(d,p), and the reactivity properties were compared between the natural derivatives of perezone and the three synthesized compounds, and the obtained results exhibited that has the best properties to bind with PARP-1. Finally, it is important to mention that displays significant inhibitory activity against MDA-MB-231 and MCF-7 cells, i.e., 145.01 and 83.17 µM, respectively.</description><subject>Amino acids</subject><subject>Cancer</subject><subject>Cell division</subject><subject>Computer software industry</subject><subject>Cyclohexenes</subject><subject>Density functionals</subject><subject>Design</subject><subject>Development and progression</subject><subject>Electrons</subject><subject>Enzymes</subject><subject>Equilibrium</subject><subject>Genetic aspects</subject><subject>Humans</subject><subject>Hydrogen bonds</subject><subject>Ligands</subject><subject>MCF-7 Cells</subject><subject>Molecular Dynamics Simulation</subject><subject>Monosaccharides</subject><subject>Neoplasms - drug therapy</subject><subject>Oncology, Experimental</subject><subject>Poly(ADP-ribose) Polymerase Inhibitors - pharmacology</subject><subject>Proteins</subject><subject>Sesquiterpenes</subject><subject>Simulation</subject><subject>Sugars</subject><subject>Sulfur</subject><subject>Sulfur compounds</subject><issn>1422-0067</issn><issn>1661-6596</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNpt0stO3DAUAFALgQql3bGuLLHpoqGOH3Hc3WhoC9KIjjoD28iJb0YeJTa1ExD9jf5wHQ0UWlW25Ne51vUDoZOcnDGmyEe77SMVhJKyKPfQUc4pzQgp5P6L_iF6HeOWEMqoUK_QISupEIqzI_TrHKLdOOxbvL73-Aru8Wrs2jHgcwj2Tg_2DuK0uoQAP72DT_jS4ZXtbOPxahjNQxr0Y5egd3itwwYG6zZ4Ofu-zHKsnZn8jR3CE7_RnTU7fh0nOteugYDn0HV4YR3EN-ig1V2Et4_tMbr-8nk9v8gW375ezmeLrOGUD5kynBVtwzmQVuQUaK2VrJWpiShMOnrOSlC5riXUsjCcgDKUNiCASWGkJuwYvd_texv8jxHiUPU2NikN7cCPsaIql2WRKkv09B-69WNwKbtJlbKY0LPa6A4q61o_BN1Mm1YzWZLEBJdJnf1HpWKgT7fqoLVp_q-AD7uAJvgYA7TVbbC9Dg9VTqrpD1Qv_0Di7x5zHesezB_89OjsN_xNqtM</recordid><startdate>20240101</startdate><enddate>20240101</enddate><creator>Rubiales-Martínez, Alejandro</creator><creator>Martínez, Joel</creator><creator>Mera-Jiménez, Elvia</creator><creator>Pérez-Flores, Javier</creator><creator>Téllez-Isaías, Guillermo</creator><creator>Miranda Ruvalcaba, René</creator><creator>Hernández-Rodríguez, Maricarmen</creator><creator>Mancilla Percino, Teresa</creator><creator>Macías Pérez, Martha Edith</creator><creator>Nicolás-Vázquez, María Inés</creator><general>MDPI AG</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-2416-2747</orcidid><orcidid>https://orcid.org/0000-0002-1979-5590</orcidid><orcidid>https://orcid.org/0000-0002-6683-6738</orcidid><orcidid>https://orcid.org/0000-0003-0722-5045</orcidid><orcidid>https://orcid.org/0000-0001-9371-1095</orcidid></search><sort><creationdate>20240101</creationdate><title>Design of Two New Sulfur Derivatives of Perezone: In Silico Study Simulation Targeting PARP-1 and In Vitro Study Validation Using Cancer Cell Lines</title><author>Rubiales-Martínez, Alejandro ; Martínez, Joel ; Mera-Jiménez, Elvia ; Pérez-Flores, Javier ; Téllez-Isaías, Guillermo ; Miranda Ruvalcaba, René ; Hernández-Rodríguez, Maricarmen ; Mancilla Percino, Teresa ; Macías Pérez, Martha Edith ; Nicolás-Vázquez, María Inés</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c424t-9d436fc44e0f512e2ba97b9db056d142138e91ab7eb76d40e9d22ce5e375d7a03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Amino acids</topic><topic>Cancer</topic><topic>Cell division</topic><topic>Computer software industry</topic><topic>Cyclohexenes</topic><topic>Density functionals</topic><topic>Design</topic><topic>Development and progression</topic><topic>Electrons</topic><topic>Enzymes</topic><topic>Equilibrium</topic><topic>Genetic aspects</topic><topic>Humans</topic><topic>Hydrogen bonds</topic><topic>Ligands</topic><topic>MCF-7 Cells</topic><topic>Molecular Dynamics Simulation</topic><topic>Monosaccharides</topic><topic>Neoplasms - drug therapy</topic><topic>Oncology, Experimental</topic><topic>Poly(ADP-ribose) Polymerase Inhibitors - pharmacology</topic><topic>Proteins</topic><topic>Sesquiterpenes</topic><topic>Simulation</topic><topic>Sugars</topic><topic>Sulfur</topic><topic>Sulfur compounds</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rubiales-Martínez, Alejandro</creatorcontrib><creatorcontrib>Martínez, Joel</creatorcontrib><creatorcontrib>Mera-Jiménez, Elvia</creatorcontrib><creatorcontrib>Pérez-Flores, Javier</creatorcontrib><creatorcontrib>Téllez-Isaías, Guillermo</creatorcontrib><creatorcontrib>Miranda Ruvalcaba, René</creatorcontrib><creatorcontrib>Hernández-Rodríguez, Maricarmen</creatorcontrib><creatorcontrib>Mancilla Percino, Teresa</creatorcontrib><creatorcontrib>Macías Pérez, Martha Edith</creatorcontrib><creatorcontrib>Nicolás-Vázquez, María Inés</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rubiales-Martínez, Alejandro</au><au>Martínez, Joel</au><au>Mera-Jiménez, Elvia</au><au>Pérez-Flores, Javier</au><au>Téllez-Isaías, Guillermo</au><au>Miranda Ruvalcaba, René</au><au>Hernández-Rodríguez, Maricarmen</au><au>Mancilla Percino, Teresa</au><au>Macías Pérez, Martha Edith</au><au>Nicolás-Vázquez, María Inés</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Design of Two New Sulfur Derivatives of Perezone: In Silico Study Simulation Targeting PARP-1 and In Vitro Study Validation Using Cancer Cell Lines</atitle><jtitle>International journal of molecular sciences</jtitle><addtitle>Int J Mol Sci</addtitle><date>2024-01-01</date><risdate>2024</risdate><volume>25</volume><issue>2</issue><spage>868</spage><pages>868-</pages><issn>1422-0067</issn><issn>1661-6596</issn><eissn>1422-0067</eissn><abstract>Poly-ADP-Ribose Polymerase (PARP-1) is an overexpressed enzyme in several carcinomas; consequently, the design of PARP-1 inhibitors has acquired special attention. Hence, in the present study, three compounds ( - ) were produced through a Michael addition protocol, using phenylmethanethiol, 5-fluoro-2-mercaptobenzyl alcohol, and 4-mercaptophenylacetic acid, respectively, as nucleophiles and perezone as the substrate, expecting them to be convenient candidates that inhibit PARP-1. It is convenient to note that in the first stage of the whole study, the molecular dynamics (MD) simulations and the quantum chemistry studies of four secondary metabolites, i.e., perezone ( ), perezone angelate ( ), hydroxyperezone ( ), and hydroxyperezone monoangelate ( ), were performed, to investigate their interactions in the active site of PARP-1. Complementarily, a docking study of a set of eleven sulfur derivatives of perezone ( - ) was projected to explore novel compounds, with remarkable affinity to PARP-1. The molecules - provided the most adequate results; therefore, they were evaluated in vitro to determine their activity towards PARP-1, with having the best IC (0.317 µM) value. Additionally, theoretical calculations were carried out using the density functional theory (DFT) with the hybrid method B3LYP with a set of base functions 6-311++G(d,p), and the reactivity properties were compared between the natural derivatives of perezone and the three synthesized compounds, and the obtained results exhibited that has the best properties to bind with PARP-1. Finally, it is important to mention that displays significant inhibitory activity against MDA-MB-231 and MCF-7 cells, i.e., 145.01 and 83.17 µM, respectively.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>38255943</pmid><doi>10.3390/ijms25020868</doi><orcidid>https://orcid.org/0000-0002-2416-2747</orcidid><orcidid>https://orcid.org/0000-0002-1979-5590</orcidid><orcidid>https://orcid.org/0000-0002-6683-6738</orcidid><orcidid>https://orcid.org/0000-0003-0722-5045</orcidid><orcidid>https://orcid.org/0000-0001-9371-1095</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1422-0067
ispartof International journal of molecular sciences, 2024-01, Vol.25 (2), p.868
issn 1422-0067
1661-6596
1422-0067
language eng
recordid cdi_proquest_miscellaneous_2917867863
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; MDPI - Multidisciplinary Digital Publishing Institute; PubMed Central
subjects Amino acids
Cancer
Cell division
Computer software industry
Cyclohexenes
Density functionals
Design
Development and progression
Electrons
Enzymes
Equilibrium
Genetic aspects
Humans
Hydrogen bonds
Ligands
MCF-7 Cells
Molecular Dynamics Simulation
Monosaccharides
Neoplasms - drug therapy
Oncology, Experimental
Poly(ADP-ribose) Polymerase Inhibitors - pharmacology
Proteins
Sesquiterpenes
Simulation
Sugars
Sulfur
Sulfur compounds
title Design of Two New Sulfur Derivatives of Perezone: In Silico Study Simulation Targeting PARP-1 and In Vitro Study Validation Using Cancer Cell Lines
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T01%3A40%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Design%20of%20Two%20New%20Sulfur%20Derivatives%20of%20Perezone:%20In%20Silico%20Study%20Simulation%20Targeting%20PARP-1%20and%20In%20Vitro%20Study%20Validation%20Using%20Cancer%20Cell%20Lines&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Rubiales-Mart%C3%ADnez,%20Alejandro&rft.date=2024-01-01&rft.volume=25&rft.issue=2&rft.spage=868&rft.pages=868-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms25020868&rft_dat=%3Cgale_proqu%3EA780876547%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2918768633&rft_id=info:pmid/38255943&rft_galeid=A780876547&rfr_iscdi=true